The role of palliative radiotherapy in bladder cancer: a narrative review
AffiliationDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
MetadataShow full item record
AbstractBladder cancer is the 6th most common cancer worldwide and contributes significant excess mortality and morbidity. It often presents at a late stage when it is incurable, and the prognosis is poor. The local symptoms of bladder cancer-including haematuria, dysuria, frequency, nocturia and pain, have significant effects on quality of life and may require frequent inpatient admissions. As a palliative treatment, radiotherapy can be uniquely useful in providing targeted long term symptomatic control, although this must be balanced against the potential of causing toxicity. A variety of radiotherapy protocols have been developed for managing these symptoms. The results of several studies show that radiotherapy delivered in a hypofractionated regime (21 Gy in 3 fractions) can provide relief of these symptoms within a few weeks. Other commonly used regimes include 35 Gy in 10 fractions, 30 Gy in 5 fractions, a once weekly 36 Gy in 6 fractions, and a single 8 Gy fraction. In the palliative setting symptom resolution lasts for the majority of the patients remaining lifespan. Benefit is particularly clear for symptomatic haematuria and in these patients even single doses may provide rapid benefit. To maximise benefit from radiotherapy, studies are urgently needed to better estimate the prognosis of patients presenting with bladder cancer.
CitationRaby SEM, Hoskin P, Choudhury A. The role of palliative radiotherapy in bladder cancer: a narrative review. Ann Palliat Med. 2020.
JournalAnnals of Palliative Medicine
- Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly.
- Authors: McLaren DB, Morrey D, Mason MD
- Issue date: 1997 May
- A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09.
- Authors: Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, Fossâ SD, Uscinska BM, Parmar MK
- Issue date: 2000 May 1
- Palliative radiation therapy of symptomatic recurrent bladder cancer.
- Authors: Yi SK, Yoder M, Zaner K, Hirsch AE
- Issue date: 2007 Mar
- A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer.
- Authors: Srinivasan V, Brown CH, Turner AG
- Issue date: 1994
- Hypofractionated radiotherapy for patients with carcinoma of the bladder.
- Authors: Jose CC, Price A, Norman A, Jay G, Huddart R, Dearnaley DP, Horwich A
- Issue date: 1999